[1]
|
Zhao D, Liu J, Wang M, et al. Epidemiology of cardiovascular disease in China: current features and implications[J].Nat Rev Cardiol, 2018. doi: 10.1038/s41569-018-0119-4.[Epub ahead of print]. |
[2]
|
李立明.中国居民营养与健康状况调查报告之四: 2002高血压[M].北京: 人民卫生出版社, 2008: 23-35. |
[3]
|
国家卫生和计划生育委员会.中国居民营养与慢性病状况报告(2015)[R].北京: 人民卫生出版社, 2015: 83-85. |
[4]
|
Wang Z, Chen Z, Zhang L, et al. Status of Hypertension in China: Results From the China Hypertension Survey, 2012-2015[J]. Circulation, 2018, 137: 2344-2356. doi: 10.1161/CIRCULATIONAHA.117.032380 |
[5]
|
Reinikainen J, Laattilcainen T, Karvanen J, et al. Lifetime cumulative risk factors predict cardiovascular disease mortality in a 50-year follow-up study in Finland[J].Int J Epidemiol, 2015, 44:108-116. doi: 10.1093/ije/dyu235 |
[6]
|
Liu K, Colangelo LA, Daviqlus ML, et al. Can Antihypertensive Treatment Restore the Risk of Cardiovascular Disease to Ideal Levels? The Coronary Artery Risk Development in Young Adults (CARDIA) Study and the Multi-Ethnic Study of Atherosclerosis (MESA)[J].J Am Heart Assoc, 2015, 4:e002275. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599509/ |
[7]
|
Wang Y, Liu J, Wang W, et al. Lifetime risk for cardiovascular disease in a Chinese population: the Chinese Multi-Provincial Cohort Study[J]. Eur J Prev Cardiol, 2015, 22:380-388. doi: 10.1177/2047487313516563 |
[8]
|
Wang Y, Liu J, Wang W, et al. Lifetime risk of stroke in young-aged and middle-aged Chinese population: the Chinese Multi-Provincial Cohort Study[J]. J Hypertens, 2016, 34:2434-2440. doi: 10.1097/HJH.0000000000001084 |
[9]
|
Berry JD, Dyer A, Cai X, et al. Lifetime risk of cardiovascular disease[J]. N Engl J Med, 2012, 366:321-329. doi: 10.1056/NEJMoa1012848 |
[10]
|
Stevens W, Peneva D, Li JZ, et al. Estimating the future burden of cardiovascular disease and the value of lipid and blood pressure control therapies in China[J]. BMC Health Serv Res, 2016, 16:175. doi: 10.1186/s12913-016-1420-8 |
[11]
|
Whelton PK, Carey RM, Aronow WS, et al.2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA /ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines[J]. Circulation, 2018, 138:e426-e483. https://pubmed.ncbi.nlm.nih.gov/29146533/ |
[12]
|
Lu Y, Wang P, Zhou T, et al. Comparison of Prevalence, Awareness, Treatment, and Control of Cardiovascular Risk Factors in China and the United States[J]. J Am Heart Assoc, 2018, pii: e007462. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=10.1161/JAHA.117.007462 |
[13]
|
李国奇, 刘静, 王薇, 等.中国35-64岁人群15年高血压发生风险预测研究[J].中华内科杂志, 2014, 53:265-268. doi: 10.3760/cma.j.issn.0578-1426.2014.04.004 |
[14]
|
Qi Y, Han X, Zhao D, et al. Long-term cardiovascular risk associated with stage 1 hypertension defined by the 2017 ACC/AHA hypertension guideline[J]. JACC, 2018, 72:1201-1210. doi: 10.1016/j.jacc.2018.06.056 |
[15]
|
Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the Global Burden of Disease Study 2013[J]. Lancet, 2016, 387:251-272. doi: 10.1016/S0140-6736(15)00551-6 |
[16]
|
GBD 2016 cause of death collaborators. Global, regional and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. Lancet, 2017, 390:1151-1210. doi: 10.1016/S0140-6736(17)32152-9 |
[17]
|
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension[J]. Eur Heart J, 2018, 39:3021-3104. doi: 10.1093/eurheartj/ehy339 |
[18]
|
《中国高血压防治指南》修订委员会.中国高血压防治指南2018年修订版[J].心脑血管病防治, 2019, 9:1-45. |